MedTrace Logo

Hip Socket Erosion Study

NCT06096883 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-08-05

No results posted yet for this study

Summary

The aim of this exploratory retrospective study is to gain a better understanding about the occurrence of acetabular erosion in patients after after hip hemiarthroplasty. The main objectives are i) to summarise a selection of basic patient characteristics of all patients of ≤ 75 years of age with a femoral neck fracture who have received either HA or THA, ii) to explore the proportion of patients after HA who developed acetabular erosion in the first years post-surgery and iii) to explore the proportion of patients after HA for whom acetabular erosion was the main reason for conversion surgery from HA to THA. A secondary objective is to assess the observer reliability of, and explore the association between, the Baker classification grading and Köhler line measurements.

All participants approached for participation in the main phase of the study will be asked to give their written informed consent to use their patient data. Patients who are willing to participate will also be asked to complete a short paper survey to collect data that is not available from their health records.

Conditions

  • Femoral Neck Fractures
  • Hemiarthroplasty
  • Acetabulum; Protrusion

Sponsors & Collaborators

  • Isala

    collaborator OTHER

  • Jeroen Bosch Ziekenhuis

    collaborator OTHER

  • Maxima Medical Center

    collaborator OTHER

  • Noordwest Ziekenhuisgroep

    collaborator OTHER

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Matthijs P. Somford, MD, PhD · Stichting Rijnstate Ziekenhuis

Eligibility

Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-19
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096883 on ClinicalTrials.gov